600976.SH
Jianmin Pharmaceutical Group Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 26.40
+0.76%Oct 21, 2026, 08:31 UTC
Jianmin Group reported revenue of 2.297 billion yuan and attributable net profit of 238 million yuan for the first three quarters of 2026, down 9.98% and 16.60% year over year, respectively.
Source:Oct 21, 2026, 08:31 UTC
Jianmin Group reported third-quarter 2026 revenue of 686 million yuan, down 8.19% year over year, and attributable net profit of 61.0818 million yuan, down 6.19%.
Source:Sep 3, 2026, 10:29 UTC
Jianmin Group announced that its Crisaborole Ointment received approval from China's National Medical Products Administration and was launched on the market.
Source:Aug 19, 2026, 08:44 UTC
Jianmin Group announced its 2026 half-year results: revenue of 1.611 billion yuan, down 10.72% year-on-year; net profit attributable to shareholders of 177 million yuan, down 19.68% year-on-year.